Special Survey on Long-term Drug Use of Mirapex-LA Tablets in Patients With Parkinson's Disease
Phase of Trial: Phase IV
Latest Information Update: 17 Aug 2015
At a glance
- Drugs Pramipexole (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 23 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 25 Jun 2014 Planned End Date changed from 1 Jun 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 25 Jun 2014 Planned primary completion date changed from 1 Jun 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov.